Preliminary Comparison of PET/CT Studies Performed After Intravenous and Oral Administration of 18F-Fluoride.
A 78-year-old man with prostate cancer was referred for 18F-NaF PET/CT for assessing bone metastases. An 18F-NaF PET/CT study was performed after the intravenous administration of the radiopharmaceutical. Five days later, a second study was done after oral administration of the radiopharmaceutical as part of a research protocol.